Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.3550
+0.0300 (9.23%)
At close: Jan 13, 2026, 4:00 PM EST
0.3540
-0.0010 (-0.28%)
After-hours: Jan 13, 2026, 7:59 PM EST
RVPH Market Cap
RVPH has a market cap or net worth of $41.48 million as of January 13, 2026. Its market cap has decreased by -49.97% in one year.
Market Cap
41.48M
Enterprise Value
28.30M
1-Year Change
-49.97%
Ranking
Category
Stock Price
$0.36
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $41.48M, an increase of 64.55%. That is a compound annual growth rate of 7.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 37.98M | 16.49% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |